Tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide
C73H82N16O10 — CID 159628445
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide
Tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide (PubChem CID 159628445) has the molecular formula C73H82N16O10 and a molecular weight of 1343.56 g/mol. Its IUPAC name is tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide.
Molecular Properties
| Compound Name | Tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide |
|---|---|
| PubChem CID | 159628445 |
| Molecular Formula | C73H82N16O10 |
| Molecular Weight | 1343.56 g/mol |
| Exact Mass | 1342.64 |
| IUPAC Name | tert-butyl (3R)-3-[[1-[(4-methoxyphenyl)methyl]-4-[4-(pyridin-2-ylcarbamoyl)phenoxy]pyrazolo[3,4-b]pyridin-3-yl]amino]pyrrolidine-1-carboxylate;(E)-4-[cyclopropyl(methyl)amino]but-2-enoic acid;4-[[3-[[(3R)-1-[(E)-4-[cyclopropyl(methyl)amino]but-2-enoyl]pyrrolidin-3-yl]amino]-1H-pyrazolo[3,4-b]pyridin-4-yl]oxy]-N-pyridin-2-ylbenzamide |
| SMILES | CN(C/C=C/C(=O)N1CC[C@@H](Nc2n[nH]c3nccc(Oc4ccc(C(=O)Nc5ccccn5)cc4)c23)C1)C1CC1.CN(C/C=C/C(=O)O)C1CC1.COc1ccc(Cn2nc(N[C@@H]3CCN(C(=O)OC(C)(C)C)C3)c3c(Oc4ccc(C(=O)Nc5ccccn5)cc4)ccnc32)cc1 |
| InChI | InChI=1S/C35H37N7O5.C30H32N8O3.C8H13NO2/c1-35(2,3)47-34(44)41-20-17-25(22-41)38-31-30-28(16-19-37-32(30)42(40-31)21-23-8-12-26(45-4)13-9-23)46-27-14-10-24(11-15-27)33(43)39-29-7-5-6-18-36-29;1-37(22-9-10-22)17-4-6-26(39)38-18-14-21(19-38)33-29-27-24(13-16-32-28(27)35-36-29)41-23-11-7-20(8-12-23)30(40)34-25-5-2-3-15-31-25;1-9(7-4-5-7)6-2-3-8(10)11/h5-16,18-19,25H,17,20-22H2,1-4H3,(H,38,40)(H,36,39,43);2-8,11-13,15-16,21-22H,9-10,14,17-19H2,1H3,(H,31,34,40)(H2,32,33,35,36);2-3,7H,4-6H2,1H3,(H,10,11)/b;6-4+;3-2+/t25-;21-;/m11./s1 |
| InChIKey | MOUNHOHWVFHCDL-QBIYEZAGSA-N |
| XLogP | 11.13 |
| TPSA | 301.64 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 23 |
| Heavy Atoms | 99 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1343.56 |
| LogP ≤ 5 | 11.13 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 20 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159628445 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.